ResearcherOdawara Municipal HospitalActive in the last 2 years
Hironobu Makino
Matched on OpenAlex author ID A5109892315. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- [Multidisciplinary Therapy Mainly Including Surgery for Hemorrhage Due to Duodenal Invasion of Pancreatic Cancer-A Case Report]. First author PMID 41546309↗
- [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formation]. Co-author PMID 28133201↗
- [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. First author PMID 26805123↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hisashi Kametaka · 3 shared papers, 2015–2025 · strength 0.38
- Paper [Multidisciplinary Therapy Mainly Including Surgery for Hemorrhage Due to Duodenal Invasion of Pancreatic Cancer-A Case… PMID 41546309↗
- Paper [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formati… PMID 28133201↗
- Paper [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. PMID 26805123↗
- Kazuhiro Seike · 3 shared papers, 2015–2025 · strength 0.38
- Paper [Multidisciplinary Therapy Mainly Including Surgery for Hemorrhage Due to Duodenal Invasion of Pancreatic Cancer-A Case… PMID 41546309↗
- Paper [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formati… PMID 28133201↗
- Paper [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. PMID 26805123↗
- Yoji Miyahara · 1 shared paper, 2025 · strength 0.25
- Akio Hasegawa · 2 shared papers, 2015–2016 · strength 0.13
- Masaru Isozaki · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.